Table 3 Individual characteristics of included patients
N | Sex | Age | AA-CCI | Primary tumor | Ablation | Procedure type | Additional hardware | Operative time (min) | EBL (mL) | Reoperation | Post-operative complication | FU (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 74 | 10 | Prostate | Yes | Simple | 124 | 50 | No | No | 5.3 | |
2 | F | 76 | 11 | Melanoma | No | Complex | THA | 315 | 300 | No | No | 44.6 |
3 | F | 57 | 4 | Multiple myeloma | No | Simple | 87 | 50 | No | No | 38.1 | |
4 | M | 73 | 10 | Prostate | No | Complex | External fixator | 361 | 500 | No | No | 37.4 |
5 | M | 62 | 5 | Multiple myeloma | No | Simple | 284 | 150 | No | No | 3 | |
6 | M | 72 | 10 | Pharyngeal SCC | No | Simple | 187 | 800 | No | No | 14.4 | |
7 | F | 69 | 9 | Endometrioid adenocarcinoma | No | Complex | Spine rod | 215 | 650 | No | No | 14.5 |
8 | F | 65 | 9 | Breast | No | Complex | THA + periacetabular PDNs | 425 | 350 | No | No | 15.1 |
9 | M | 73 | 12 | RCC | No | Complex | Femur IMN | 219 | 500 | No | No | 17 |
10 | M | 70 | 12 | Hepatocellular | No | Complex | THA + periacetabular PDNs | 435 | 900 | No | No | 15.6 |
11 | F | 57 | 9 | Lung | No | Simple | 119 | 50 | No | No | 19.4 | |
12 | F | 59 | 2 | Thyroid | Yes | Complex | Periacetabular PDNs | 174 | 50 | No | No | 10.6 |
13 | F | 68 | 9 | Breast | No | Simple | 156 | 150 | No | No | 22.5 | |
14 | M | 70 | 11 | Thyroid | No | Simple | 98 | 25 | No | No | 33.5 |